I am a senior researcher specializing in anticancer drug development and preclinical evaluation. My research focuses on translational oncology, cancer immunology, and disease modeling. I develop and validate in vitro and in vivo platforms, including organoids, xenografts, and humanized mouse models, to evaluate the efficacy and safety of novel therapeutics. My interests also include biomarker discovery and translational medicine.